These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22565949)

  • 1. Fifth time's the charm for infant respiratory distress drug.
    Katsnelson A
    Nat Biotechnol; 2012 May; 30(5):380. PubMed ID: 22565949
    [No Abstract]   [Full Text] [Related]  

  • 2. Fifth time's the charm?
    Hersher R
    Nat Med; 2012 Feb; 18(2):186. PubMed ID: 22310673
    [No Abstract]   [Full Text] [Related]  

  • 3. Surfactant trials.
    Moya FR; Sinha SK; D'Agostino R
    Pediatrics; 2006 Jan; 117(1):245-7; author reply 247-8. PubMed ID: 16396889
    [No Abstract]   [Full Text] [Related]  

  • 4. Evolution of pulmonary surfactants for the treatment of neonatal respiratory distress syndrome and paediatric lung diseases.
    Mazela J; Merritt TA; Gadzinowski J; Sinha S
    Acta Paediatr; 2006 Sep; 95(9):1036-48. PubMed ID: 16938747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactant respiratory therapy using Surfaxin/sinapultide.
    Lal MK; Sinha SK
    Ther Adv Respir Dis; 2008 Oct; 2(5):339-44. PubMed ID: 19124381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lucinactant approved for respiratory distress syndrome.
    Traynor K
    Am J Health Syst Pharm; 2012 Apr; 69(8):628. PubMed ID: 22472860
    [No Abstract]   [Full Text] [Related]  

  • 7. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
    Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G;
    Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lucinactant for the treatment of respiratory distress syndrome in neonates.
    Piehl E; Fernandez-Bustamante A
    Drugs Today (Barc); 2012 Sep; 48(9):587-93. PubMed ID: 23032799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lucinactant: a novel synthetic surfactant for the treatment of respiratory distress syndrome.
    Donn SM
    Expert Opin Investig Drugs; 2005 Mar; 14(3):329-34. PubMed ID: 15833063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic surfactants: the search goes on.
    Kattwinkel J
    Pediatrics; 2005 Apr; 115(4):1075-6. PubMed ID: 15805389
    [No Abstract]   [Full Text] [Related]  

  • 11. Colfosceril palmitate (Exosurf)--artificial surfactant for immature lungs.
    Drug Ther Bull; 1991 Jun; 29(12):46. PubMed ID: 1935584
    [No Abstract]   [Full Text] [Related]  

  • 12. Aerosolized lucinactant: a potential alternative to intratracheal surfactant replacement therapy.
    Donn SM; Sinha SK
    Expert Opin Pharmacother; 2008 Feb; 9(3):475-8. PubMed ID: 18220497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
    N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surfactant treatment of neonatal acute respiratory distress syndrome: is "fortification" the answer?
    Chima RS; Zingarelli B
    Crit Care Med; 2007 Oct; 35(10):2442-3. PubMed ID: 17885382
    [No Abstract]   [Full Text] [Related]  

  • 15. [Surfactant-associated proteins B and C: molecular biology and physiologic properties].
    Gortner L; Hilgendorff A
    Z Geburtshilfe Neonatol; 2004 Jun; 208(3):91-7. PubMed ID: 15229816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Criteria for use of colfosceril (Exosurf) in neonates.
    Bhatt-Mehta V; Schumacher RE
    Clin Pharm; 1992 Apr; 11(4):355-7. PubMed ID: 1563234
    [No Abstract]   [Full Text] [Related]  

  • 17. Surfactant for respiratory distress syndrome.
    Bierman SF
    N Engl J Med; 1989 Sep; 321(12):834. PubMed ID: 2671737
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug treatments of respiratory distress syndrome in premature infants].
    Saliba E; Laugier J
    Pediatrie; 1993; 48(12):864-71. PubMed ID: 8047397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial reconstituted pulmonary surfactant in prevention and treatment of respiratory distress syndrome in neonates.
    Jiang ZQ; Sun GM; Ma YM
    Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):182-4. PubMed ID: 10072978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on pulmonary surfactant replacement for neonates.
    Engel NS
    MCN Am J Matern Child Nurs; 1990; 15(3):189. PubMed ID: 2113980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.